Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondria, NO and neurodegeneration.

M F Beal1

  • 1Neurochemistry Laboratory, Neurology Service/WRN 408, Massachusetts General Hospital, Boston, USA.

Biochemical Society Symposium
|September 16, 2000
PubMed
Summary

Mitochondrial dysfunction is increasingly linked to neurodegenerative diseases like Friedreich

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy.

Cell death and differentiation·2015
Same author

Impaired brain creatine kinase activity in Huntington's disease.

Neuro-degenerative diseases·2010
Same author

Influence of mitochondrial enzyme deficiency on adult neurogenesis in mouse models of neurodegenerative diseases.

Neuroscience·2008
Same author

Neuroprotective and neurorestorative strategies for neuronal injury.

Neurotoxicity research·2006
Same author

Prospects for redox-based therapy in neurodegenerative diseases.

Neurotoxicity research·2006
Same author

Retraction.

Proceedings of the National Academy of Sciences of the United States of America·2006

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • Mitochondrial dysfunction is implicated in various neurodegenerative diseases.
  • Pathways include free-radical generation, calcium dysregulation, and mitochondrial permeability transition.
  • This dysfunction can result in both apoptotic and necrotic cell death.

Purpose of the Study:

  • To review the growing evidence linking mitochondrial dysfunction to neurodegenerative diseases.
  • To explore potential therapeutic strategies targeting mitochondrial defects.

Main Methods:

  • Review of existing scientific literature and studies.
  • Examination of evidence from specific diseases like Friedreich's ataxia, amyotrophic lateral sclerosis, Huntington's disease, Parkinson's disease, and Alzheimer's disease.
  • Analysis of cybrid cell line studies.

Main Results:

  • Mitochondrial defects are observed in Friedreich's ataxia, linked to increased free radicals.
  • Point mutations in superoxide dismutase may contribute to mitochondrial dysfunction in ALS.
  • Evidence suggests bioenergetic defects in Huntington's disease and mitochondrial involvement in Parkinson's and Alzheimer's diseases.

Conclusions:

  • Mitochondrial dysfunction is a significant factor in the pathogenesis of multiple neurodegenerative diseases.
  • Therapeutic interventions like coenzyme Q10 and creatine show potential for slowing disease progression.

Related Experiment Videos